Proposition - PharmXpert Academy

464 2007 Korea Pharmaceutical Industry Directory
2. Main Products Information
No.
The Name of
Products
Main Ingredient
Use
(Indications)
Formulation
The Date
of Sales
Expected
Exporting
Countries
Etc.
1
Neuronox Botulinum
Toxin type A
Human Serum Albumin,
Sodium Chloride
spasmodic
winking
Injection
3. R&D Figures
Type A
Type B
Type E
100 units
50, 200 units
Liquid type inj.
2nd generation botulinum toxin inj. with longer effects
Indication-specialized inj.
Process development
Pre-clinical toxicology studies
(Rodent, Non-Rodent)
Process development
4. Patent Information
No
The Name of Technology
Application
No.
(Application
date)
Publication
No.
(Publication
date)
Priority
No.
Applied
Country
For Global
Development
Stage
Future
Plan
Expected
Licencing
(Domestic,
Oversea)
1
A process for the purification
of Clostridium botulinum
neurotoxin type B using
immnuno-affinity
chromatography
2004-0078541
(2004.10.02)
0561163
(2006.03.08)